nanoComposix attending TechConnect Nanotech 2023
nanoComposix (now a Fortis Life Sciences company) is thrilled to announce its participation as an exhibitor at the TechConnect Nanotech 2023 conference! Visit us at booth #306 to meet our...
Read MoreFortis Life Sciences Acquires nanoComposix
Fortis Life Sciences has completed its acquisition of nanoComposix, a premium nanomaterials company focused on solutions for assay development and diagnostics. Since 2004, nanoComposix has built one of the most...
Read MorenanoComposix Expands Italian Distribution Channels with Prodotti Gianni
SAN DIEGO, California – nanoComposix expands Italian distribution channels with Prodotti Gianni (ricerca.prodottigianni.com), who has over 60 years of experience distributing life science reagents in Italy. Prodotti has a strong...
Read MorenanoComposix offers full-service lateral flow assay CDMO development services & high-capacity medical device manufacturing, making it the complete solution for start-to-finish assay production
nanoComposix is uniting its lateral flow assay development services with high-volume automated medical device manufacturing to offer fully custom start-to-finish assay production managed by industry experts. For nearly two decades,...
Read MoreExpanded Manufacturing Capability for Large Scale Production of 40 nm Gold Nanoparticles
SAN DIEGO, California – nanoComposix has improved its process development for scaling up the 40 nm gold citrate particles for use in lateral flow diagnostic assays. This capability can expand...
Read MorenanoComposix Partners with Pró-Análise to Expand Distribution of nanoComposix Nanoparticles to Customers In Brazil
SAN DIEGO, California – nanoComposix has signed an agreement with Pró-Análise (pro-analise.com.br) to broaden the distribution of nanoComposix products to customers throughout Brazil. nanoComposix (nanocomposix.com) manufactures hundreds of off-the-shelf and...
Read MoreExpanded automated manufacturing at nanoComposix adds the capability to produce millions of high-quality lateral flow rapid tests per month
nanoComposix has expanded its lateral flow rapid test manufacturing capacity with the installation of BioDot reel-to-reel dispensers and laminators. The manufacturing expansion allows for the production of millions of lateral...
Read MorenanoComposix Completes ISO 13485:2016 Certification for Quality Management System
SAN DIEGO, California – nanoComposix is proud to announce successful expansion of its Quality Management System (QMS) to include ISO 13485:2016 certification*. The certification demonstrates that the nanoComposix QMS satisfies the current...
Read MorenanoComposix Partners with BIOZOL Diagnostica Vertrieb GmbH to Widen Distribution of nanoComposix Nanoparticles to Customers Across Germany
SAN DIEGO, California – nanoComposix has signed an agreement with BIOZOL Diagnostica Vertrieb GmbH (biozol.de/de) to broaden the distribution of nanoComposix products to customers throughout Germany and Austria. nanoComposix (nanocomposix.com)...
Read MoreAnnouncing nanoComposix & University of Minnesota Joint Webinar
Advancement in nanowarming and the impact on critical animal models for drug therapies and genetic studies In this webinar, Dr. Bischof and Dr. Kholsa will be joining us from the...
Read MoreFluroTech and nanoComposix Announce Joint Venture SARS-CoV2 Test Method Optimization
CALGARY, Alberta, Nov. 12, 2020 (GLOBE NEWSWIRE) – FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that has begun optimization of its SARS-CoV2 rapid detection...
Read MoreTherma Bright and Orpheus Medica Advance CoviSafe™ Rapid Saliva Test to Formal Product Developmental Phase
Successful completion of feasibility studies followed by engagement of nanoComposix to accelerate the development of CoviSafe™ Toronto, Ontario – Therma Bright Inc. (TSXV: THRM) (“Therma” or the “Company”), a progressive...
Read MorenanoComposix Signs Agreement with Amplicon Biotech to Expand Product Distribution to Customers Throughout India
San Diego, California – nanoComposix has established a partnership with Amplicon Biotech (www.amplicon.in/) to expand access for customers across India to the suite of products and services offered by nanoComposix,...
Read MorenanoComposix’s COVID-19 Update
During this turbulent time, we wanted to update you on our response to the COVID-19 epidemic and the steps nanoComposix is taking as we continue to operate in the midst of...
Read MorenanoComposix Partners with EM Japan to Widen Distribution of nanoComposix Nanoparticles to Customers Across Japan
SAN DIEGO, California – nanoComposix has signed an agreement with EM Japan (https://www.em-japan.com/) to broaden the distribution of nanoComposix products to customers throughout Japan. nanoComposix (www.nanocomposix.com) manufactures an array of...
Read MorenanoComposix Receives Funding to Enhance Sensitivity of Rapid Diagnostics for Cytomegalovirus by Incorporating Gold Nanoshells
SAN DIEGO, California – nanoComposix was recently awarded NIAID Phase II Small Business Innovation Research (SBIR) funding to develop a rapid, accurate, and inexpensive point of care (POC) diagnostic that...
Read MorenanoComposix is Awarded NIAID Grant to Develop Mesoporous Nanoparticles for HIV Vaccine with Unprecedented Drug Delivery Control
SAN DIEGO, California – nanoComposix was awarded funding from the National Institute of Allergy and Infectious Diseases (NIAID) to design novel nanoparticles for development of an HIV vaccine with enhanced...
Read MorenanoComposix Expands Capabilities to Include Drug Manufacturing
SAN DIEGO, California – NanoComposix, a nanotechnology development and contract manufacturing company, recently received its Drug Manufacturing License from the Food and Drug Branch of the State of California Department...
Read MorenanoComposix Establishes Partnership with Veritas for Distribution of nanoComposix Nanoparticles in Japan
SAN DIEGO, California – nanoComposix has announced that they have partnered with Veritas (www.veritastk.co.jp/) to improve access for customers in Japan to the suite of nanoparticle products and services offered...
Read MorenanoComposix Partners with CliniSciences to Broaden Distribution of Products to Customers Throughout Europe
San Diego, California – nanoComposix has signed an agreement with CliniSciences (www.clinisciences.com), establishing a partnership toward expanding the distribution of nanoComposix materials and technologies to customers throughout Europe. nanoComposix (www.nanocomposix.com)...
Read MoreDiagnosing with Novel Nanoparticles
Learn more about nanoparticles for lateral flow Visit our Knowledge Base
Read MorenanoComposix expands its full-service lateral flow assay development services using novel ultra-sensitive nanoparticle reporters, covalent binding chemistry, and quantitative smartphone-based reader technologies for better lateral flow assays
San Diego, CA – nanoComposix, Inc., a global supplier of the widest variety of precisely engineered, highly characterized nanoparticles, has expanded its lateral flow services to provide full-service lateral flow...
Read MorenanoComposix Awarded STTR Funding to Develop Nanoparticle-Based Technologies for the Cryopreservation of Zebrafish Embryos
San Diego, CA – nanoComposix, Inc., a global supplier of precisely engineered, highly characterized nanoparticles, announced that it was awarded a Phase I contract of $225,000 to investigate the cryopreservation...
Read MoreTutorial: Nanoparticle Characterization
In this nanoComposix tutorial, our Characterization Services manager, David, gives a roundup of the importance of various nanoparticle characterization techniques and how they work. If you need your nanoparticle characterized,...
Read MoreWebinar: 7 Critical Steps for Optimizing Your Lateral Flow Assay
In this webinar, you’ll learn techniques to optimize the 7 components that are critical when developing your assay. Our lateral flow experts Rhea and Jean will teach you the secrets...
Read MoreUV-Visible Spectroscopy Measurement Tutorial for Nanoparticle Solutions, Part 2
The second part in a series on how to accurately measure the optical spectra of solutions of nanoparticles using a UV-VIS (UV-Visible) spectroscopy. In this demo, we use an Agilent...
Read MoreCovalent Coupling of Antibodies to Carboxyl Gold Nanoparticles
This video provides step-by-step instruction for how to conjugate antibodies to nanoComposix’s BioReady carboxyl gold nanoparticles. Learn how to make high sensitivity conjugates with low non-specific background on your first...
Read MoreNanosafety: Conclusions from a decade of nanotoxicology research
Are nanoparticles safe? This webinar provides a summary of what we've learned over the last 10 years providing support for nanotoxicology research. Guidance is provided on important factors that toxicologists...
Read MorenanoComposix Signs Agreement with i-DNA Biotechnology Pte. Ltd. for Distribution of its Products in Singapore and Malaysia
nanoComposix announced it that has selected and signed an agreement with i-DNA Biotechnology Pte. Ltd. for distribution of nanoComposix nanotechnology products and services in Southeast Asia. nanoComposix is a 12...
Read MorenanoComposix Signs Agreement with Stratech Ltd. for Distribution of its Products in the United Kingdom
nanoComposix Signs Agreement with Stratech Ltd. for Distribution of its Products in the United Kingdom nanoComposix announced it that has selected and signed an agreement with Stratech Scientific Ltd. for...
Read More